Key Takeaways
- C3.ai is scheduled to release Q1 FY27 financial results on September 2, with analyst consensus forecasting $52 million in revenue and a $0.26 per share adjusted loss.
- DA Davidson’s Lucky Schreiner maintains a Sell rating with a $7 price target, suggesting potential downside of 35.3% from present trading levels.
- Shares have declined approximately 20% since the start of the year, despite posting an 11% gain in the most recent month.
- TipRanks shows an average analyst price target of $9.29 for AI stock, indicating possible 14.2% decline; overall rating stands at Moderate Sell.
- The enterprise AI firm reduced its workforce by 35% during the current year and anticipates approximately $1 million in net new revenue for the upcoming quarter.
The enterprise artificial intelligence software provider C3.ai (AI) will unveil its fiscal first quarter 2027 results after market close on Wednesday, September 2. Shares are currently hovering near $10.90, reflecting a roughly 20% decline year-to-date.
Analyst consensus calls for the company to report $52 million in quarterly revenue alongside an adjusted per-share loss of $0.26. These projections would mark a year-over-year revenue contraction of approximately 25.7%.
Among Wall Street analysts, at least one voice stands notably pessimistic. DA Davidson’s Lucky Schreiner has maintained his Sell rating while setting a $7 price target, suggesting the stock could fall 35.3% from its current trading price.
Schreiner’s bearish perspective stems from ongoing execution challenges and constrained near-term profit potential. Despite the company’s aggressive 35% workforce reduction this year, he argues the valuation remains excessive relative to fundamentals.
Recent trading activity shows modest positive momentum, with shares advancing 11% during the past month as investor sentiment toward C3.ai’s software-as-a-service model improved. However, this performance trails the broader data and analytics software sector, which climbed 14.7% during the same timeframe.
Financial Performance Analysis
C3.ai’s most recent quarterly disclosure presented contrasting signals. While revenue of $51.6 million surpassed analyst projections, it represented a sharp 52.5% year-over-year decline. The company exceeded expectations on adjusted operating income while falling short on billings metrics.
Subscription revenue has remained essentially stagnant across the previous two quarters. Demonstration license revenue has completely dried up, and the pipeline for net new revenue continues to look sparse.
Management issued preliminary fiscal 2027 guidance during the previous quarter, forecasting a 10% annual revenue decline. Current consensus estimates of approximately $225 million align with the midpoint of that projection range. Schreiner anticipates management will elevate the lower bound of FY27 guidance when reporting these results.
Factors That Could Shift Sentiment
Tom Siebel’s resumption of the chief executive position represents a potentially constructive development in Schreiner’s assessment. Enhanced sales performance and expanded professional services revenue stand out as two domains where Siebel’s leadership could yield meaningful improvements.
The company has strategically pivoted toward enterprise-scale clients and sophisticated AI implementations. During its pre-earnings quiet period communication, C3.ai indicated that market appetite for AI capabilities remains robust, while customers are developing sharper understanding of the company’s competitive differentiation.
Government sector opportunities represent another promising growth avenue that Schreiner highlighted in his analysis.
Recent earnings from industry peers have yielded varied outcomes. Elastic delivered 15.1% revenue expansion and exceeded forecasts by 1.7%, propelling its shares 21.8% higher. Conversely, Teradata posted stagnant revenue, surpassed estimates by 3.5%, yet still experienced a 23.7% stock decline.
According to TipRanks data, AI stock holds a Moderate Sell consensus rating derived from one Buy recommendation, three Hold ratings, and five Sell ratings. The $9.29 average analyst price target suggests 14.2% downside from present trading levels.





